[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

Recent MHRA Alerts

by Jackie (née Heneghan) Peck | May 20, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

So much for all the wonders and claims of slimming tablets … After investigation, the MHRA has recently issued alerts about a number of products found to have prescription only drug ingredients in them.  All the alerts were raised by the Hong Kong Department of...

Export of medicines in short supply………

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

The PSNC is no longer maintaining a list as shortages have become part of every day life in pharmacy now. This posed a question by one of my clients: “Does this mean we can now export anything?” No I said you must not export drugs in short supply and I refereed him to...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Out of Specification (OOS) Test Results

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Pharmacy Suppliers, Regulation

What are Out of Specification results (OOS)?  It seems to be clear enough in the name but I thought I better check it out. One definition is: All test results which fall outside the specifications or acceptance criteria established in drug applications, drug master...

Wholesale Dealer or Distributor? Wholesale Licence or Authorisation?

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog

Which one do you have? I know we now have to have a wholesale distribution authorisation (WDA ) to wholesale medicines but I still find myself saying wholesale dealers licence and wholesale dealers authorisation. Why the change? We have to come into line with the rest...
« Older Entries
Next Entries »

Recent Posts

  • CPD Accreditation – Directory listing
  • Tobacco and Vapes Bill becomes law
  • Medicines Supply Shortages and the impact on pharmacies when Drug Tariff prices do not keep up with the cost of drugs

Upcoming Courses

  • Licence Holder Training on 3 August 2026 10:00 am
  • RP Forum – tbc on 4 August 2026 10:00 am
  • Superintendent Pharmacist training (Online) on 7 August 2026
  • GDP/RP Cogent Gold Standard Online Training on 18 August 2026
  • Introduction to Good Distribution Practice Online Training on 21 August 2026 10:00 am

MHRA Alerts & Recalls

MHRA Safety Roundup: July 2026
30 July 2026
Field Safety Notices: 29 June to 03 July 2026
29 July 2026
Field Safety Notices: 20 to 24 July 2026
28 July 2026
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
23 July 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow